Trials / Completed
CompletedNCT03226093
Safety Analysis of Implantation of Stromal Vascular Fraction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 676 (actual)
- Sponsor
- Bioheart, Inc. · Industry
- Sex
- All
- Age
- 15 Years – 97 Years
- Healthy volunteers
- Not accepted
Summary
Stromal vascular fraction (SVF) can be isolated from fat (adipose) tissue in an outpatient in-clinic procedure. Platelet rich plasma (PRP) can be isolated from peripheral blood. The SVF includes a variety of different cells and growth factors where the adipocyte (fat cell) population has been removed. The use of SVF in the clinic for a variety of indications is analyzed for incidences of safety and tolerability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Stromal Vascular Fraction | The fat was separated via centrifuge to isolate the SVF and the cells were delivered intraarticularly, intravenously, intrathecally, or intradiscally directly into the same patient |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-06-01
- First posted
- 2017-07-21
- Last updated
- 2017-07-21
Source: ClinicalTrials.gov record NCT03226093. Inclusion in this directory is not an endorsement.